| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Kania, Aneta
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (5/5 displayed)
- 2022Evaluation of the biocompability and corrosion activity of resorbable CaMgZnYbBAu alloyscitations
- 2022Amorphous and Crystalline Magnesium Alloys for Biomedical Applicationscitations
- 2021The influence of rapid solidification on corrosion behavior of Mg60Zn20Yb15.7Ca2.6Sr1.7 alloy for medical applications
- 2020Effect of the Thickness of TiO2 Films on the Structure and Corrosion Behavior of Mg-Based Alloyscitations
- 2019Mechanical and Corrosion Properties of Mg-Based Alloys with Gd Additioncitations
Places of action
| Organizations | Location | People |
|---|
booksection
Amorphous and Crystalline Magnesium Alloys for Biomedical Applications
Abstract
<jats:p>Amorphous and crystalline magnesium alloys, developed for medical applications – especially implantology – present the characteristics of biocompatible magnesium alloys (Mg-Zn, Mg-Zn-Ca, Mg-Ca etc.). This chapter provides a brief description of the role of magnesium in the human body and the use of Mg in medicine. It presents the concept of using magnesium alloys in medicine (advantages and limitations) and the scope of their potential applications (orthopedic implantology, cardiac surgery etc.). The chapter shows classification of magnesium alloys as potential biomaterials, due to their structure (amorphous, crystalline) and alloying elements (rare earth elements, noble metals etc.). The mechanism and in vitro degradation behavior of magnesium alloys with amorphous and crystalline structures are described. The chapter also discusses the influence of alloying elements (rare earth elements, noble metals) on the in vitro degradation process. It also presents the methods of reducing the degradation rate of magnesium alloys by modifying their surface (application of protective layers).</jats:p>